Identification and Treatment Of Micrometastatic Disease in Stage III Colon Cancer
Status:
Recruiting
Trial end date:
2023-02-01
Target enrollment:
Participant gender:
Summary
This research study is comparing two standard of care treatment options based on blood test
results for participants who have metastatic colorectal cancer.
The names of the potential treatments involved in this study are:
- Active surveillance
- FOLFIRI treatment
- Nivolumab treatment
- Encorafenib/Binimetinib/Cetuximab treatment